Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1343613rdf:typepubmed:Citationlld:pubmed
pubmed-article:1343613lifeskim:mentionsumls-concept:C0025663lld:lifeskim
pubmed-article:1343613lifeskim:mentionsumls-concept:C0004153lld:lifeskim
pubmed-article:1343613lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:1343613lifeskim:mentionsumls-concept:C1417035lld:lifeskim
pubmed-article:1343613lifeskim:mentionsumls-concept:C0684321lld:lifeskim
pubmed-article:1343613lifeskim:mentionsumls-concept:C1442488lld:lifeskim
pubmed-article:1343613lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:1343613lifeskim:mentionsumls-concept:C0242747lld:lifeskim
pubmed-article:1343613lifeskim:mentionsumls-concept:C1707689lld:lifeskim
pubmed-article:1343613pubmed:dateCreated1994-3-17lld:pubmed
pubmed-article:1343613pubmed:abstractTextThe Monitored Atherosclerosis Regression Study (MARS) was designed to evaluate the effect of cholesterol lowering by monotherapy with an HMG-CoA reductase inhibitor on progression/regression of atherosclerosis in subjects with angiographically documented coronary artery disease. The purpose of this paper is to present the design, methods, and baseline results of MARS.lld:pubmed
pubmed-article:1343613pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1343613pubmed:languageenglld:pubmed
pubmed-article:1343613pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1343613pubmed:citationSubsetIMlld:pubmed
pubmed-article:1343613pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1343613pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1343613pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1343613pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1343613pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1343613pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1343613pubmed:statusMEDLINElld:pubmed
pubmed-article:1343613pubmed:monthOctlld:pubmed
pubmed-article:1343613pubmed:issn1059-2725lld:pubmed
pubmed-article:1343613pubmed:authorpubmed-author:HirschL JLJlld:pubmed
pubmed-article:1343613pubmed:authorpubmed-author:AzenS PSPlld:pubmed
pubmed-article:1343613pubmed:authorpubmed-author:KramschD MDMlld:pubmed
pubmed-article:1343613pubmed:authorpubmed-author:HwangIIlld:pubmed
pubmed-article:1343613pubmed:authorpubmed-author:DeBoerLLlld:pubmed
pubmed-article:1343613pubmed:authorpubmed-author:LoboF GFGlld:pubmed
pubmed-article:1343613pubmed:authorpubmed-author:DeMetsDDlld:pubmed
pubmed-article:1343613pubmed:authorpubmed-author:DeBoerL WLWlld:pubmed
pubmed-article:1343613pubmed:authorpubmed-author:Cashin-Hemphi...lld:pubmed
pubmed-article:1343613pubmed:authorpubmed-author:VailasLLlld:pubmed
pubmed-article:1343613pubmed:issnTypeElectroniclld:pubmed
pubmed-article:1343613pubmed:day23lld:pubmed
pubmed-article:1343613pubmed:volumeDoc No 26lld:pubmed
pubmed-article:1343613pubmed:ownerNLMlld:pubmed
pubmed-article:1343613pubmed:authorsCompleteNlld:pubmed
pubmed-article:1343613pubmed:pagination[9897 words; 83 paragraphs]lld:pubmed
pubmed-article:1343613pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:1343613pubmed:meshHeadingpubmed-meshheading:1343613-...lld:pubmed
pubmed-article:1343613pubmed:meshHeadingpubmed-meshheading:1343613-...lld:pubmed
pubmed-article:1343613pubmed:meshHeadingpubmed-meshheading:1343613-...lld:pubmed
pubmed-article:1343613pubmed:meshHeadingpubmed-meshheading:1343613-...lld:pubmed
pubmed-article:1343613pubmed:meshHeadingpubmed-meshheading:1343613-...lld:pubmed
pubmed-article:1343613pubmed:meshHeadingpubmed-meshheading:1343613-...lld:pubmed
pubmed-article:1343613pubmed:meshHeadingpubmed-meshheading:1343613-...lld:pubmed
pubmed-article:1343613pubmed:meshHeadingpubmed-meshheading:1343613-...lld:pubmed
pubmed-article:1343613pubmed:meshHeadingpubmed-meshheading:1343613-...lld:pubmed
pubmed-article:1343613pubmed:meshHeadingpubmed-meshheading:1343613-...lld:pubmed
pubmed-article:1343613pubmed:meshHeadingpubmed-meshheading:1343613-...lld:pubmed
pubmed-article:1343613pubmed:meshHeadingpubmed-meshheading:1343613-...lld:pubmed
pubmed-article:1343613pubmed:meshHeadingpubmed-meshheading:1343613-...lld:pubmed
pubmed-article:1343613pubmed:meshHeadingpubmed-meshheading:1343613-...lld:pubmed
pubmed-article:1343613pubmed:meshHeadingpubmed-meshheading:1343613-...lld:pubmed
pubmed-article:1343613pubmed:meshHeadingpubmed-meshheading:1343613-...lld:pubmed
pubmed-article:1343613pubmed:meshHeadingpubmed-meshheading:1343613-...lld:pubmed
pubmed-article:1343613pubmed:meshHeadingpubmed-meshheading:1343613-...lld:pubmed
pubmed-article:1343613pubmed:year1992lld:pubmed
pubmed-article:1343613pubmed:articleTitleThe Monitored Atherosclerosis Regression Study (MARS). Design, methods and baseline results.lld:pubmed
pubmed-article:1343613pubmed:affiliationAtherosclerosis Research Institute, University of Southern California School of Medicine, Los Angeles 90033.lld:pubmed
pubmed-article:1343613pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1343613pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:1343613pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:1343613pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed